Industry news

NSF-DBA experts bring you the latest news updates from the industry

EXCiPACT™ AUDITOR TRAINING COURSES

Wednesday the 16th May 2012

Dear Pharmaceutical Excipient Suppliers’ Auditors and Auditees,

You are cordially invited to attend one of the next 2-day EXCiPACT™ AUDITOR TRAINING COURSES in BRUSSELS on either 16/17 July, 2012 or 18/19 July, 2012.

Course Objective: Working knowledge of the EXCiPACT™ GMP and GDP standards

... Read more

NSF-DBA cherche un ou plusieurs Consultants associés

Saturday the 5th May 2012

NSF-DBA cherche un ou plusieurs Consultants associés indépendants pour proposer nos services en conseil pharmaceutique, en audit et en formation pour nos clients francophones.

Les candidats choisis, seront indépendants, avec de l’expérience professionnelle pharmaceutique, peut-être même avec l...

Read more

ICH Q11 Receives Step Four Approval

Friday the 27th April 2012

Please be aware that Q11 received step 4 approvals from the ICH steering committee on 24 April. The final step 5 is implementation by the national/regional authorities and this is expected to occur within the next 6 months.

The step 4 version has not yet been published on the ICH website.

Be...

Read more

Final CHMP Guidance on 'Real Time Release Testing'

Thursday the 26th April 2012

In late March 2012 the EMA issued the final version of CHMP note for guidance (NfG) on Guideline on Real Time Release Testing (RTRT). This is new guidance replaces the previous guidance on parametric release (CPMP/QWP/3015/99) from 1 October 2012. The previous guidance only applied to the releas...

Read more

New draft CHMP Guidance on Process Validation

Wednesday the 18th April 2012

Peter Gough reviews:

Dear All,

In late March 2012 the EMA published a draft CHMP Guideline on Process validation that proposes to replace the existing CHMP Guidance’s on this topic (CPM/QWP/848/96 and EMEA/CVMP/598/99). Comments on this proposal are due to EMA by 31 October 2012. Unlike the ...

Read more

Quick links

NSF-DBA have offices in Kirkbymoorside UK, Boston and Ann Arbor USA and South Africa

A word from NSF-DBA

The legislation and guidance that apply to the healthcare industries is forever changing. NSF-DBA will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

Peter Gough

NSF-DBA Partner

© NSF-DBA 2012

Registered Office: NSF-DBA, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: mail@nsf-dba.com
US Office: NSF-DBA LLC, 6th floor, 129 South St, Boston, MA 02111 | Tel: 617-342-3625 | Fax: 617-342-3623 | Email: USinfo@nsf-dba.com
SA Office: NSF-DBA, PO Box 2440, Faerie Glen, 0043 | Tel: +27 (0)714 999 614 | Fax: +27 (0)86 568 1887 | Email: ajt@nsf-dba.com